This activity is expired and is no longer available for CME credit.


Ranibizumab in the Management of Diabetic Macular Edema: Where Do We Stand in 2013?

Author(s)/Faculty: Michael S. Ip, MD; Amol Kulkarni, MD
Release Date: 11/1/2013Expiration Date: 10/31/2014
Credit Type: CMENumber of Credits: 0
Content Type: MonographProvider:
Diabetic macular edema (DME) is a primary cause of vision loss in the working-age population. The treatment paradigm for this condition has shifted with the advent of intravitreal anti–vascular endothelial growth factor (VEGF) medications, several of which have been demonstrated to be safe and effective for treating DME...